- Home
- TARS vs DXC Comparison
TARS vs DXC Comparison
Compare TARS & DXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | DXC |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARS | DXC |
|---|---|---|
| Price | $71.64 | $14.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $76.56 | $15.33 |
| AVG Volume (30 Days) | 709.0K | ★ 1.6M |
| Earning Date | 02-24-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1492.90 |
| EPS | N/A | ★ 2.03 |
| Revenue | $366,100,000.00 | ★ $12,714,000,000.00 |
| Revenue This Year | $147.34 | N/A |
| Revenue Next Year | $53.50 | N/A |
| P/E Ratio | ★ N/A | $7.19 |
| Revenue Growth | ★ 182.44 | N/A |
| 52 Week Low | $38.51 | $11.82 |
| 52 Week High | $85.25 | $23.75 |
Technical Indicators
Market Signals| Indicator | TARS | DXC |
|---|---|---|
| Relative Strength Index (RSI) | 26.51 | 47.83 |
| Support Level | $76.91 | $14.79 |
| Resistance Level | $76.22 | $15.59 |
| Average True Range (ATR) | 3.15 | 0.48 |
| MACD | -1.09 | -0.06 |
| Stochastic Oscillator | 0.12 | 41.18 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About DXC DXC Technology Company
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.